Cargando…
A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China
BACKGROUND: Pharmacogenomics (PGx) examines the influence of genetic variation on drug responses. With more and more Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines published, PGx is gradually shifting from the reactive testing of single gene toward the preemptive testing of mu...
Autores principales: | Huang, Quanfei, Liao, Yuwei, Yu, Tao, Lei, Wei, Liang, Hongfeng, Wen, Jianxin, Liu, Qing, Chen, Yu, Huang, Kaisheng, Jing, Lifang, Huang, Xiaoyan, Liu, Yuanru, Yu, Xiaokang, Su, Kaichan, Liu, Tengfei, Yang, Liye, Huang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098050/ https://www.ncbi.nlm.nih.gov/pubmed/36916827 http://dx.doi.org/10.1002/jcla.24855 |
Ejemplares similares
-
Detecting mitochondrial mutations associated with aminoglycoside ototoxicity by noninvasive prenatal testing
por: Huang, Quanfei, et al.
Publicado: (2022) -
Development and use of active clinical decision support for preemptive pharmacogenomics
por: Bell, Gillian C, et al.
Publicado: (2014) -
Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy
por: Roosan, Don, et al.
Publicado: (2020) -
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing
por: Van Driest, Sara L., et al.
Publicado: (2013) -
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China
por: Liu, Yanhui, et al.
Publicado: (2020)